Improving primary care after stroke: testing a new stroke service

Improving Primary Care After Stroke (IPCAS): a pilot of a cluster randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN58449011

Enrollment

100

Registered

2017-04-06

Start date

2017-07-09

Completion date

Unknown

Last updated

2022-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Specialty: Primary Care, Primary sub-specialty: Stroke

Interventions

At baseline, patients will be sent an information pack and baseline questionnaires inviting them to the study by the General Practice. Consent to participate will be given by returning the consent for

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Diagnosis of stroke 2. Has a good understanding of English 3. Has the capacity to provide written informed consent. 4. Age = 18 years 5. Gender: both males and females

Exclusion criteria

Exclusion criteria: 1. Patients with a history of transient ischaemic attack (TIA) only 2. Bed-bound patients 3. People unable to provide written informed consent due to mental illness or cognitive impairment 4. Patients considered by the GP to be unsuitable for example: terminal illness 5. Living in residential care

Design outcomes

Primary

Measure	Time frame
Feasibility will be assessed as: 1.1. The recruitment rate will be recorded as percent of eligible patients invited who consent to the study 1.2. The uptake rate to the intervention will be recorded as: 1.2.1. Percent of consented patients who attend the annual review by the end of the intervention (by 6 months) and 1.2.2. The number of times the DPoC was contacted by 6 months 1.3. Percent of fully completed baseline and follow-up questionnaires by 6 months	—

Measure

Time frame

Feasibility will be assessed as: 1.1. The recruitment rate will be recorded as percent of eligible patients invited who consent to the study 1.2. The uptake rate to the intervention will be recorded as: 1.2.1. Percent of consented patients who attend the annual review by the end of the intervention (by 6 months) and 1.2.2. The number of times the DPoC was contacted by 6 months 1.3. Percent of fully completed baseline and follow-up questionnaires by 6 months

—

Secondary

Measure	Time frame
1. Feasibility is further assessed by recording: 1.1. Reasons why people are not reviewed will be recorded in patient medical records and reviewed at 6 months 1.2. Additional workload for the Practice associated with the model will be recorded based on patient medical records: The length of the reviews (mean, standard deviation; SD) and the number of times each patient is seen 1.3. The overall number of referrals made by 6 months 1.4. Call durations to the DPoC (mean, SD) 2. Acceptability is assessed using information on barriers and facilitators about the uptake to the study, recorded during the debriefing meeting	—

Measure

Time frame

1. Feasibility is further assessed by recording: 1.1. Reasons why people are not reviewed will be recorded in patient medical records and reviewed at 6 months 1.2. Additional workload for the Practice associated with the model will be recorded based on patient medical records: The length of the reviews (mean, standard deviation; SD) and the number of times each patient is seen 1.3. The overall number of referrals made by 6 months 1.4. Call durations to the DPoC (mean, SD) 2. Acceptability is assessed using information on barriers and facilitators about the uptake to the study, recorded during the debriefing meeting

—

Countries

England, United Kingdom

Contacts

Public ContactLizzie Kreit

ek445@medschl.cam.ac.uk+44 (0)1223 762502

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026